Fidelity · Technology Sector
Fidelity Advisor Biotechnology Fund: share classes compared
Fidelity Advisor Biotechnology Fund has 5 share classes. They hold the same portfolio — $2.2 billion in total — but charge different fees and loads. The cheapest is FIJYX (Class Z) at 0.57%.
| Ticker | Share class | Type | Expense ratio | Front load | 12b-1 | 1-yr | 5-yr | 10-yr |
|---|---|---|---|---|---|---|---|---|
| FBTAX | Class A | Mutual fund | 0.94% | — | 0.25% | +31.5% | +6.4% | +7.7% |
| FBTIX | Class I | Mutual fund | 0.69% | — | 0% | +39.9% | +7.9% | +8.6% |
| FBTTX | Class M | Mutual fund | 1.19% | — | 0.5% | +34.4% | +6.6% | +7.6% |
| FBTCX | Class C | Mutual fund | 1.69% | — | 1% | +37.5% | +6.8% | +7.7% |
| FIJYX | Class Z | Mutual fund | 0.57% | — | 0% | +40.1% | +8.1% | — |
Source: Fund prospectus, filed Sep 24, 2026
Objective
Fidelity Advisor Biotechnology Fund seeks capital appreciation.
Top holdings
- Abbvie Inc — 14.71%
- Gilead Sciences Inc — 5.70%
- Spyre Therapeutics Inc — 3.83%
- Alnylam Pharmaceuticals Inc — 3.62%
- Dianthus Therapeutics Inc — 3.55%
- Cogent Biosciences Inc — 3.25%
- Oruka Therapeutics Inc — 3.24%
- Insmed Inc — 3.05%
- Revolution Medicines Inc — 3.00%
- Argenx Se — 3.00%